To obtain a more global view on the effect of the APOBEC3B deletion on cancer, we conducted a comprehensive meta-analysis that considered all case-control studies of the deletion (including our own) performed using cases with different cancer types (predominantly breast cancer). The gene discussed is APOBEC3B; the disease is cancer.